Trial Profile

Effect of vilazodone on cardiac repolarisation

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Aug 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vilazodone (Primary) ; Moxifloxacin
Indications Bacterial infections; Major depressive disorder
Focus Adverse reactions

Most Recent Events

25 Aug 2013 Status changed from not stated to completed.
10 Dec 2010 New trial record
06 Dec 2010 Results were presented at the annual meeting of the American Society of Health System Pharmacists (ASHP), according to a Clinical Data Inc media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com